News Focus
News Focus
Replies to #94959 on Biotech Values
icon url

DewDiligence

04/29/10 5:04 PM

#94961 RE: DewDiligence #94959

ITMN: Roughly 2/3 of the US patient pool for Esbriet is Medicare eligible, according to Dan Welch.
icon url

ghmm

04/30/10 4:29 AM

#94982 RE: DewDiligence #94959

ITMN:

For what its worth going back for probably at least a year Dan Welch talked about hiring sales rep's only after approval. Managers were planned to be hired only after a possible favor panel review. So I think there is no change from their plan. Perhaps learning from the ENCY fiasco :-).

Did you happen to catch the questions/comments about the FDA meeting tomorrow (today) regarding using multiple anti-virals in HCV? Do you know anything more about this, if its something that is publicly broadcasted? TIA